However, in this paper, we present a novel observation that malignant cells of neuroectodermal origin, namely melanoma and glioblastoma cells, are capable of efficient synthesis and release of bHB when treated with a synthetic PPARa agonist, fenofibrate. This evidence concerns the gene PPARA and glioblastoma.